JP2008509889A5 - - Google Patents

Download PDF

Info

Publication number
JP2008509889A5
JP2008509889A5 JP2007519454A JP2007519454A JP2008509889A5 JP 2008509889 A5 JP2008509889 A5 JP 2008509889A5 JP 2007519454 A JP2007519454 A JP 2007519454A JP 2007519454 A JP2007519454 A JP 2007519454A JP 2008509889 A5 JP2008509889 A5 JP 2008509889A5
Authority
JP
Japan
Prior art keywords
interferon
polyol
conjugate
moiety
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007519454A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008509889A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/023383 external-priority patent/WO2006004959A2/en
Publication of JP2008509889A publication Critical patent/JP2008509889A/ja
Publication of JP2008509889A5 publication Critical patent/JP2008509889A5/ja
Pending legal-status Critical Current

Links

JP2007519454A 2004-06-30 2005-06-30 ペグ化インターフェロンα−1b Pending JP2008509889A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58450404P 2004-06-30 2004-06-30
US68915505P 2005-06-09 2005-06-09
PCT/US2005/023383 WO2006004959A2 (en) 2004-06-30 2005-06-30 Pegylated interferon alpha-1b

Publications (2)

Publication Number Publication Date
JP2008509889A JP2008509889A (ja) 2008-04-03
JP2008509889A5 true JP2008509889A5 (https=) 2008-08-14

Family

ID=35783370

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007519454A Pending JP2008509889A (ja) 2004-06-30 2005-06-30 ペグ化インターフェロンα−1b

Country Status (6)

Country Link
US (1) US20060029573A1 (https=)
EP (1) EP1771197A2 (https=)
JP (1) JP2008509889A (https=)
AU (1) AU2005260664A1 (https=)
CA (1) CA2572751A1 (https=)
WO (1) WO2006004959A2 (https=)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7214660B2 (en) 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
US7173003B2 (en) 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
EP2055189A1 (en) 2003-04-09 2009-05-06 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
WO2005012484A2 (en) * 2003-07-25 2005-02-10 Neose Technologies, Inc. Antibody-toxin conjugates
US8633157B2 (en) 2003-11-24 2014-01-21 Novo Nordisk A/S Glycopegylated erythropoietin
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
US20080015142A1 (en) * 2003-12-03 2008-01-17 Defrees Shawn Glycopegylated Follicle Stimulating Hormone
WO2006010143A2 (en) 2004-07-13 2006-01-26 Neose Technologies, Inc. Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1]
US20080176790A1 (en) 2004-10-29 2008-07-24 Defrees Shawn Remodeling and Glycopegylation of Fibroblast Growth Factor (Fgf)
US9029331B2 (en) * 2005-01-10 2015-05-12 Novo Nordisk A/S Glycopegylated granulocyte colony stimulating factor
US20070154992A1 (en) * 2005-04-08 2007-07-05 Neose Technologies, Inc. Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
US20070105755A1 (en) * 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
WO2007056191A2 (en) 2005-11-03 2007-05-18 Neose Technologies, Inc. Nucleotide sugar purification using membranes
AR078117A1 (es) 2006-06-20 2011-10-19 Protech Pharma S A Una muteina recombinante del interferon alfa humano glicosilado, un gen que codifica para dicha muteina, un metodo de produccion de dicho gen, un metodo para obtener una celula eucariota productora de dicha muteina, un metodo para producir dicha muteina, un procedimiento para purificar dicha muteina
ES2516694T3 (es) * 2006-07-21 2014-10-31 Ratiopharm Gmbh Glicosilación de péptidos a través de secuencias de glicosilación con unión en O
US8969532B2 (en) * 2006-10-03 2015-03-03 Novo Nordisk A/S Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography
US20100041872A1 (en) * 2006-10-04 2010-02-18 Defrees Shawn Glycerol linked pegylated sugars and glycopeptides
CN1970572A (zh) * 2006-12-21 2007-05-30 北京三元基因工程有限公司 干扰素α突变体及其聚乙二醇衍生物
KR20100016160A (ko) * 2007-04-03 2010-02-12 바이오제너릭스 에이지 글리코페길화 g―csf를 이용하는 치료 방법
WO2008154639A2 (en) * 2007-06-12 2008-12-18 Neose Technologies, Inc. Improved process for the production of nucleotide sugars
FR2927075A1 (fr) * 2008-02-04 2009-08-07 Centre Nat Rech Scient Molecules comprenant un squelette bis-(heteroaryl)maleimide, et leur utilisation dans l'inhibition d'enzymes
KR101582841B1 (ko) 2008-02-27 2016-01-11 노보 노르디스크 에이/에스 콘쥬게이트된 인자 viii 분자
CN101928341B (zh) * 2010-06-30 2014-05-28 深圳科兴生物工程有限公司 分离重组人干扰素α1b异构体的纯化工艺及其检测方法
RU2447083C1 (ru) * 2010-07-20 2012-04-10 Закрытое Акционерное Общество "Биокад" НОВЫЙ ФУНКЦИОНАЛЬНО АКТИВНЫЙ ВЫСОКООЧИЩЕННЫЙ СТАБИЛЬНЫЙ КОНЪЮГАТ ИНТЕРФЕРОНА α С ПОЛИЭТИЛЕНГЛИКОЛЕМ, ПРЕДСТАВЛЕННЫЙ ОДНИМ ПОЗИЦИОННЫМ ИЗОМЕРОМ ПЭГ-NαH-ИФН, С УМЕНЬШЕННОЙ ИММУНОГЕННОСТЬЮ, С ПРОЛОНГИРОВАННЫМ БИОЛОГИЧЕСКИМ ДЕЙСТВИЕМ, ПРИГОДНЫЙ ДЛЯ МЕДИЦИНСКОГО ПРИМЕНЕНИЯ, И ИММУНОБИОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ
BR112014005091A2 (pt) 2011-09-05 2017-06-13 Beijing Hanmi Pharmaceutical Co Ltd composição farmacêutica para o tratamento do câncer compreendendo conjugado de interferon alfa
JP7689079B2 (ja) * 2019-03-28 2025-06-05 オリオニス バイオサイエンシズ,インコーポレイテッド 治療用インターフェロンアルファ1タンパク質
CN112569359A (zh) * 2019-09-30 2021-03-30 上海生物制品研究所有限责任公司 培干扰素和原癌基因产物靶向抑制剂在协同治疗肾癌中的应用
CN112569358B (zh) * 2019-09-30 2022-06-28 上海生物制品研究所有限责任公司 培干扰素和原癌基因产物靶向抑制剂在协同抑制肿瘤中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0205404B1 (en) * 1985-06-11 1992-07-15 Ciba-Geigy Ag Hybrid interferons
US5206344A (en) * 1985-06-26 1993-04-27 Cetus Oncology Corporation Interleukin-2 muteins and polymer conjugation thereof
US5166322A (en) * 1989-04-21 1992-11-24 Genetics Institute Cysteine added variants of interleukin-3 and chemical modifications thereof
US5766897A (en) * 1990-06-21 1998-06-16 Incyte Pharmaceuticals, Inc. Cysteine-pegylated proteins
US6335160B1 (en) * 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
US5824784A (en) * 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods
TW517067B (en) * 1996-05-31 2003-01-11 Hoffmann La Roche Interferon conjugates
US6026716A (en) * 1997-05-19 2000-02-22 Tool Research Corporation Supergrip plier-wrench tool
DK1656952T3 (da) * 1998-10-16 2014-01-20 Biogen Idec Inc Polyalkylenglycolkonjugater af interferon beta-1A og anvendelser deraf
JP2005517648A (ja) * 2001-12-07 2005-06-16 インターミューン インコーポレイテッド 肝炎ウイルス感染症を治療するための組成物および方法
US20050054053A1 (en) * 2002-10-01 2005-03-10 Xencor, Inc. Interferon variants with improved properties
EP1565205A4 (en) * 2002-11-18 2006-07-05 Maxygen Inc Interferon-alpha polypeptides and conjugates

Similar Documents

Publication Publication Date Title
JP2008509889A5 (https=)
CA2312976C (en) Compositions comprising histidine-linked protein polymer conjugates
EP0862455B1 (en) Interferon-polymer conjugates and process for preparing the same
EP1037657B1 (en) Alpha-interferon-polymer-conjugates having enhanced biological activity and methods of preparing the same
TW570802B (en) Improved interferon polymer conjugates
US5711944A (en) Interferon polymer conjugates
CN1376164A (zh) Gcsf缀合物
JP2009503111A (ja) G−csf部分および重合体の複合体
JPH11310600A (ja) N末端化学修飾タンパク質組成物および方法
JP2008509889A (ja) ペグ化インターフェロンα−1b
JP2007533665A (ja) 新規g−csf結合体
WO2006094530A1 (en) Di-polymer protein conjugates and processes for their preparation
CN104961831B (zh) 一种修饰的重组人内皮抑素及其应用
JP2005512951A (ja) 化学修飾されたプロゲニポイエチンコンジュゲート
CN1569892A (zh) 多臂树杈型聚乙二醇与蛋白质或多肽的结合物及其制备方法
EP1834963A1 (en) Di-polymer protein conjugates and processes for their preparation
JPWO2003000278A1 (ja) 軟膏剤
KR20130137966A (ko) 생체적합성 고분자가 접합된 단백질 및 이의 제조방법